Suyog Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 28-07-2024
- Paid Up Capital ₹ 4.68 Cr
as on 28-07-2024
- Company Age 34 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 28-07-2024
- Satisfied Charges ₹ 18.86 Cr
as on 28-07-2024
- Revenue -0.64%
(FY 2023)
- Profit -17.09%
(FY 2023)
- Ebitda -24.29%
(FY 2023)
- Net Worth -237.69%
(FY 2023)
- Total Assets -2.16%
(FY 2023)
About Suyog Pharmaceuticals
The Corporate was formerly known as Suyog Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.68 Cr.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹18.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Shah, Jayesh Shah, Bharatkumar Vasavada, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239MH1990PTC055025
- Company No.
055025
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Suyog Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Shah  | Director | 12-Jul-1990 | Current |
| Jayesh Shah | Director | 12-Jul-1990 | Current |
| Bharatkumar Vasavada | Whole-Time Director | 01-Oct-2006 | Current |
| Hema Shah | Director | 01-Apr-2022 | Current |
Financial Performance of Suyog Pharmaceuticals.
Suyog Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.64% decrease. The company also saw a substantial fall in profitability, with a 17.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 237.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suyog Pharmaceuticals?
In 2023, Suyog Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
G. Loucatos And Company Private LimitedActive 42 years 10 monthsRakesh Shah, Jayesh Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2016 | ₹5.00 M | Open |
Others Creation Date: 15 Sep 2016 | ₹6.23 Cr | Satisfied |
The Saraswat Co-Operative Bank Ltd Creation Date: 12 Apr 2012 | ₹3.75 M | Satisfied |
How Many Employees Work at Suyog Pharmaceuticals?
Suyog Pharmaceuticals has a workforce of 43 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suyog Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suyog Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
